comparemela.com
Home
Live Updates
CellVax Therapeutics Announces FDA Clearance of IND Application for FK-PC101, a Novel Personalized Cancer Immunotherapy : comparemela.com
CellVax Therapeutics Announces FDA Clearance of IND Application for FK-PC101, a Novel Personalized Cancer Immunotherapy
/PRNewswire/ -- Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell-based therapies, has announced that its sponsor client, CellVax...
Related Keywords
Canada ,
Fernando Kreutz ,
Scott Eggener ,
Society Of Urologic Oncology ,
Contract Development Manufacturing Organization In Arcadia ,
Cellvax Therapeutics Inc ,
Md University Of Chicago As Principal Investigator ,
Drug Administration ,
Prnewswire Theragent Inc ,
Society Of Urologic Oncology Clinical Trials Consortium ,
Investigational New Drug ,
Major Histocompatibility Complex ,
Urologic Oncology Clinical Trials Consortium ,
Yun Yen ,
Chief Financial ,
Vax Therapeutics ,
Contract Development Manufacturing Organization ,
Urologic Oncology ,
comparemela.com © 2020. All Rights Reserved.